"Accuri Cytometers Secures $6M to Break into Clinical IVD Market" Genetic Engineering & Biotechnology News, August, 2010. www.Genengnews.com
Accuri Cytometers (www.accuricytometers.com completed a $6 million Series preferred-stock financing to support expansion of the Accuri C6 Flow Cytometer, a bench top cell-analysis system, into the clinical in vitro diagnostics market. Accuri is currently implementing an ISO 13485 Quality System in preparation for the planned European launch of the Accuri C6 Flow Cytometer with CE-IVD mark certification for clinical use, to be followed by a 510(k) regulatory submission to the FDA seeking clearance to market the Accuri C6 Flow Cytometer for clinical IVD applications in the U.S.